Earlier this month, pharmaphorum editor-in-chief Jonah Comstock had the opportunity to visit the headquarters of the Novo Nordisk Foundation in Copenhagen, Denmark to talk to several innova
Cell and gene therapies continue to be hot topics in the pharma world this year, and some companies are responding to the new treatment modalities with new business units.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
